Table 4 Interrupted time series analysis results considering the impact of reserve status on trends or revenue/sales/price levels.
From: Changes in revenues associated with antimicrobial reimbursement reforms in Germany
p-values | ||||
|---|---|---|---|---|
Pre-reserve status trend | Post-reserve status level change | Post-reserve status trend change | Post-reserve status trend | |
Avibactam/Ceftazidime | ||||
Revenue | <0.0001 | 0.2841 | <0.0001 | 0.0103 |
Sales Volume | <0.0001 | 0.5665 | <0.0001 | 0.1183 |
Price | 0.5425 | 0.0549 | 0.0003 | 0.0002 |
Cefiderocol | ||||
Revenue | <0.0001 | 0.011 | <0.0001 | 0.0053 |
Sales volume | <0.0001 | 0.0303 | <0.0001 | 0.0002 |
Price | <0.0001 | 0.1957 | 0.0006 | <0.0001 |
